grifolan LE

a 1-3 glucan with single unit 1-6 branches every third residue; has antineoplastic activity; isolated from Grifola frondosa; carbohydrate sequence in first source

Also Known As:

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Related Diseases

1.	Sarcoma 180 10/01/1986 - "The mice cured from the solid form of sarcoma 180 by administration of grifolan LE had the ability to reject the same tumor cell. " 10/01/1986 - "The pretreatment of sarcoma 180 cell with grifolan LE in vitro did not affect tumor growth. " 10/01/1986 - "Grifolan LE was not effective on the ascites form of sarcoma 180. " 10/01/1986 - "By intraperitoneal (i.p.) administration (100-200 micrograms/mouse/d X 5) at days 1 to 9 from the tumor transplantation, grifolan LE showed marked inhibitory activity on the growth of solid form sarcoma 180 in ICR mice. "
2.	Neoplasms (Cancer) 10/01/1986 - "administration of grifolan LE at a dose of 100 micrograms/mouse/d X 5 before the tumor transplantation showed significant inhibition of tumor growth. " 10/01/1986 - "The mice cured from the solid form of sarcoma 180 by administration of grifolan LE had the ability to reject the same tumor cell. " 10/01/1986 - "The pretreatment of sarcoma 180 cell with grifolan LE in vitro did not affect tumor growth. " 10/01/1986 - "By intraperitoneal (i.p.) administration (100-200 micrograms/mouse/d X 5) at days 1 to 9 from the tumor transplantation, grifolan LE showed marked inhibitory activity on the growth of solid form sarcoma 180 in ICR mice. "
3.	Ascites 10/01/1986 - "Grifolan LE was not effective on the ascites form of sarcoma 180. "

Related Therapies and Procedures

1.	Transplantation